Mirvetuximab Soravtansine Gynx 43624-0012-01
- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- November 14, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirvetuximab Soravtansine-Gynx | 100 mg/20mL |
Selected Package
43624-0012-01Selected4 TRAY in 1 BOX (43624-012-01) / 81 VIAL, SINGLE-DOSE in 1 TRAY / 20 mL in 1 VIAL, SINGLE-DOSE